MetLife Investment Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76.1K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $27.5K | Sell |
|
|||||
|
2024
Q3 | $149K | Sell |
|
|||||
|
2024
Q2 | $197K | Buy |
|
|||||
|
2024
Q1 | $281K | Sell |
|
|||||
|
2023
Q4 | $165K | Hold |
|
|||||
|
2023
Q3 | $93.3K | Hold |
|
|||||
|
2023
Q2 | $209K | Hold |
|
|||||
|
2023
Q1 | $251K | Hold |
|
|||||
|
2022
Q4 | $444K | Hold |
|
|||||
|
2022
Q3 | $986K | Hold |
|
|||||
|
2022
Q2 | $1.09M | Hold |
|
|||||
|
2022
Q1 | $1.71M | Buy |
|
|||||
|
2021
Q4 | $1.66M | Hold |
|
|||||
|
2021
Q3 | $1.68M | Hold |
|
|||||
|
2021
Q2 | $2.46M | Hold |
|
|||||
|
2021
Q1 | $2.34M | Sell |
|
|||||
|
2020
Q4 | $2.6M | Sell |
|
|||||
|
2020
Q3 | $1.21M | Buy |
|
|||||
|
2020
Q2 | $923K | Hold |
|
|||||
|
2020
Q1 | $598K | Hold |
|
|||||
|
2019
Q4 | $527K | Buy |
|
|||||
|
2019
Q3 | $361K | Sell |
|
|||||
|
2019
Q2 | $566K | Hold |
|
|||||
|
2019
Q1 | $490K | Hold |
|
|||||
|
2018
Q4 | $358K | Buy |
|
|||||
|
2018
Q3 | $376K | Hold |
|
|||||
|
2018
Q2 | $262K | Hold |
|
|||||
|
2018
Q1 | $225K | Buy |
|